Health TrialsbyHealthPanel

Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System

ConditionOpiod Use Disorder
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorUniversity of Illinois at Chicago

About this trial

This study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system.

The main questions this study aims to answer are:

1. Does the C-DOSETaP System increase screening for patients with OUD; 2. Does the C-DOSETaP System improve continuity of health care for patients with OUD; 3. Does the C-DOSETaP System increase use of medications for opioid use disorder; and 4. Does the C-DOSETaP System reduce the number of opioid-related deaths in the neighborhoods served.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Participant must be a patient seen at the University of Illinois Hospital and Clinics

Adults and adolescents age 16 or older

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • OUD screening

    Other intervention

    Completed screening for opioid use disorder

  • MOUD

    Other intervention

    Medication treatment for opioid use disorder

  • Continuity of care

    Other intervention

    Facilitation of outpatient treatment linkages

Treatment groups

271,031 Participants
are divided into 1 treatment group
Group A: Patients with OUDExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Number of people screened for OUD

Aggregate rate of data-driven OUD screening across the health system

Time frame
Rolling measure of annual rates (12 months) measured over the implementation period.
2

Continuity of care for patients with OUD

Continuity of care will be assessed through appointment follow-up and completion of referral to the next care site within 30 days.

Time frame
30 days and 12 months
3

Utilization of MOUD across the health system

MOUD use will be measured as the number of patients actively on MOUD as a proportion of all patients within the health system and of those with documented OUD within the health system as defined by International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes.

Time frame
Baseline and 12 months

Secondary outcomes

1

Regional opioid-related mortality

Quarterly opioid-related mortality rate by zip codes served by the primary institution reported to the Illinois Department of Public Health

Time frame
Baseline and 12 months
2

Regional OUD Screening

Quarterly opioid-related screening rates by zip codes served by the primary institution reported to the Illinois Department of Public Health

Time frame
Baseline and 12 months
3

Regional MOUD utilization

Quarterly MOUD utilization rates by zip codes served by the primary institution reported to the Illinois Department of Public Health

Time frame
Baseline and 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Illinois at Chicago

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: